Showing 1801-1810 of 3366 results for "".
New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21235/News
https://practicaldermatology.com/topics/general-topics/news/21281/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0509_05-php/22827/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/Dealing with Prescription Prior Authorization in Dermatology
https://practicaldermatology.com/topics/practice-management/dealing-with-prescription-prior-authorization-in-dermatology/22079/Complaints and concerns abound, but remedies are slow in coming.Pearls for Management of Steroid-Responsive Dermatoses
https://practicaldermatology.com/topics/general-topics/pearls-for-management-of-steroid-responsive-dermatoses/21958/From side effects to therapeutic combinations to consider, here is an update on the latest approaches to management of steroid-responsive dermatoses.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-34/23707/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-13/23272/Diagnosing Zika; Aspire Higher Scholarship Program; Call for Abstracts
https://practicaldermatology.com/youngmd-connect/resident-resource-center/diagnosing-zika-aspire-higher-scholarship-program-call-for-abstracts/20517/Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of Imlygic